News

Paul Janssen Futurelab IP course starts April 19th

The J&J/Janssen Covid-19 vaccine that was recently approved by the FDA and EMA is produced using cell line PER.C6 that was originally developed and patented for a quite different application (i.e. gene therapy).
Paul Janssen Futurelab IP course starts April 19th

TargED Biopharmaceuticals and Good Biomarker Sciences receive MIT R&D collaboration grant

We are very pleased to announce that Economic Board Utrecht has granted €213.000 to support a 2-year joint R&D program between TargED Biopharmaceuticals and Good Biomarker Sciences.
TargED Biopharmaceuticals and Good Biomarker Sciences receive MIT R&D collaboration grant

Levels Diagnostics awarded the MIT R&D grant

Levels Diagnostics was awarded the MIT R&D grant by the Provide of South Holland. Together with Omnigen and SG papertronics the consortium will develop a test that can quickly identify early signs of liver damage in patients.
Levels Diagnostics awarded the MIT R&D grant

cristal-therapeutics-and-intravacc-announce-strategic-collaboration-to-advance-novel-vaccine-platforms

Bilthoven and Maastricht, the Netherlands, 6 January 2021 – Intravacc, a world leader in translational research and development of vaccines, and Cristal Therapeutics, a technology leader in enabling safer and more effective therapeutics, to
cristal-therapeutics-and-intravacc-announce-strategic-collaboration-to-advance-novel-vaccine-platforms

TargED awarded NWO Take-Off Phase II grant for the development of Microlyse - a next-generation thrombolytic clot-busting drug

We are very pleased to announce that The Netherlands Organization for Scientific Research (NWO) has granted the Take-Off Phase II loan (€250.000) for the further development of our lead compound, Microlyse.
TargED awarded NWO Take-Off Phase II grant for the development of Microlyse - a next-generation thrombolytic clot-busting drug

The Winner of the Venture Challenge Fall 2020 is SLAM Orthopedic!

This year’s winners of the Venture Challenge were uniquely announced in front of an online audience at the Dutch Life Sciences Conference.
The Winner of the Venture Challenge Fall 2020 is SLAM Orthopedic!

The Winner of the Venture Challenge Summer 2020 is PacingCure!

This year’s winners of the Venture Challenge were uniquely announced in front of an online audience at the Dutch Life Sciences Conference.
The Winner of the Venture Challenge Summer 2020 is PacingCure!

UNIIQ invests €200,000 in Venture Challenge winner BIMINI Biotech

BIMINI Biotech, an innovative therapeutics startup that develops new cancer drugs, has secured an investment of €200,000 from proof-of-concept fund UNIIQ to further develop its technology.
UNIIQ invests €200,000 in Venture Challenge winner BIMINI Biotech

Venture Challenge alumni TargED closes seed investment

TargED (formerly IOVA) closes seed investment and partners with UMC Utrecht for the development of Microlyse - a next-generation thrombolytic clot-busting drug  TargED Biopharmaceuticals, a biotech spin-
Venture Challenge alumni TargED closes seed investment

Venture Challenge alumnus Toxys is selected as one of the FD Gazelles of 2020

Toxys is very proud to announce that they been selected as one of the FD Gazelles of 2020.
Venture Challenge alumnus Toxys is selected as one of the FD Gazelles of 2020